News
Wegovy Maker Novo Nordisk Dumps Hims & Hers Relationship Over Claims of Deceptive Marketing
Mr. Funk was the managing editor of Pleroma Media, and worked as a breaking news reporter at The Messenger after spending 25 years at Fox Television as a producer, executive producer, and digital content director.
Daily Voice on MSN20h
Plainsboro-Based Wegovy Provider Ends Hims & Hers Deal Over Knockoff Weight-Loss Drug SalesNovo Nordisk has ended its partnership with Hims & Hers Health after two months, accusing the telehealth company of pushing ...
Wegovy is only approved for obesity in India. Novo Nordisk has no immediate plans to launch Ozempic for type 2 diabetes, ...
Globally, Wegovy recorded $8 billion in sales last year, while Ozempic — the same drug approved for diabetes — earned $17 ... India is the third most obese country after the US and China.
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback